In-Med Prognostics L3C
About In-Med Prognostics L3C
In-Med Prognostics, also known as InMed AI, is a pioneering healthcare AI company specializing in AI-driven predictive analytics, leveraging multi-modal data including text, signal, and image to develop automated, organ-agnostic imaging platforms. Their flagship product, NeuroShield™, is a US FDA 510(k) cleared AI-powered MR volumetric solution. This tool provides comprehensive brain structure analysis with absolute volumes, intracranial volume (ICV) percentages, and uniquely, age, gender, and ethnicity-adjusted reference ranges across over 30 structures, thereby contributing significantly to precision medicine.
NeuroShield™ is crucial for the early detection of atrophy in various neurodegenerative disorders such as dementia, Alzheimer’s, Parkinson’s, and epilepsy, assisting clinicians in formulating timely and effective treatment plans. The company also offers NeuroShield™ CT TBI, an AI-based neurotrauma screening and quantification tool that automates stroke lesion segmentation and midline shift detection, supporting rapid clinical decision-making in critical care. In-Med Prognostics is actively expanding its product portfolio to include CT Brain applications, Whole Body MRI wellness and athletic solutions, and lesion detection for pancreatic and liver cancer.
The company’s overarching mission is to deliver affordable, accessible, reliable, and state-of-the-art healthcare tools globally, with a strong commitment to addressing the needs of traditionally underserved and underrepresented populations in both global north and south markets.
Focus Areas
Business Intelligence
| Key Investors | Exxora, Research and Innovation Circle of Hyderabad, Venture Center, BIRAC, IIIT-H Foundation, Sriram Natarajan |
| Partnerships | Aarthi Scans, Scansworld, Gujarat Scans, Nanavati Hospital, Kauvery Hospital, Sahyadri Hospital, Deenanath Mangeshkar Hospital, Arthi diagnostic center, NM Medical, P.H diagnostic Center, Noble Hospital |
| Technology | Cloud-based software platform, AI/Deep Net/3D Convolutional Networks, machine learning, deep learning algorithms, multi-modal data (text, signal, image), automated image processing algorithms and AI/ML pipelines, end-to-end fully automated organ agnostic imaging platform |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, In-Med Prognostics L3C offers a powerful suite of tools to enhance diagnostic accuracy and treatment planning, particularly in neurology. Their AI-driven predictive analytics can provide earlier insights into brain health and neurological disorders, potentially improving patient outcomes. The ethnicity-specific reference ranges are a significant differentiator, allowing for more precise and relevant interpretations for diverse patient populations. The cloud-based clinical decision support system is designed to streamline workflows, reduce cognitive load, and provide rapid access to critical information, ultimately supporting more informed and efficient patient care. Consider how their neurotrauma decision support can integrate into your emergency and critical care protocols, and how their brain volumetry can aid in monitoring disease progression or treatment efficacy.
In-Med Prognostics L3C's cloud-based platform suggests potential for seamless integration with existing hospital information systems (HIS), electronic health records (EHR), and picture archiving and communication systems (PACS) to facilitate data flow and workflow optimization. Specific integration capabilities would likely involve standard APIs and data exchange protocols to ensure compatibility and ease of deployment within diverse clinical IT environments.
Reviews & Opinions
Videos
News, demos, and interviews about In-Med Prognostics L3C.
Videos load interactively. If none appear, search YouTube for In-Med Prognostics L3C →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]